REYVOW (lasmiditan) tablets, for oral use, [CV in USA] - FOR EXPORT ONLY
Initial U.S. Approval: 2020

PACKAGE LABEL - REYVOW 50 mg 4ct carton - FOR EXPORT ONLY

NDC 0002-0265-04

4 tablets (1 card of 4 tablets)

REYVOW™

(lasmiditan)

tablets 50 mg

For oral use.

Each tablet contains 50 mg of lasmiditan.

Rx only

50 mg

Dispense enclosed Medication Guide to each patient.

Lilly

PACKAGE LABEL - REYVOW 100 mg 4ct carton - FOR EXPORT ONLY

NDC 0002-0632-04

4 tablets (1 card of 4 tablets)

REYVOW™

(lasmiditan)

tablets 100 mg

For oral use.

Each tablet contains 100 mg of lasmiditan.

Rx only

100 mg

Dispense enclosed Medication Guide to each patient.

Lilly